Philip Taylor | Investor Relations |
Drew Spaventa | Founder and Chief Executive Officer |
Dalen Meeter | Head, Finance |
Eli Glezer | Founder and Chief Scientific Officer |
Matt Sykes | Goldman Sachs |
Michael Ryskin | Bank of America |
John Sourbeer | UBS |
Tom Stevens | Cowen |
Good afternoon, ladies and gentlemen, and welcome to the Singular Genomics’ First Quarter 2022 Earnings Conference Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Philip Taylor. Sir, the floor is yours.
Thank you, operator. Presenting today are Singular Genomics’ Founder and Chief Executive Officer, Drew Spaventa; and Head of Finance, Dalen Meeter.